Financials
Financial year 2024
PHARMA SOLUTIONS from Sint-Niklaas, company number BE0468526628, closed financial year 2024 with a result of € 65,461 after tax. For that financial year PHARMA SOLUTIONS recorded a gross margin of € 81,126 and equity of € 99,060. Compared with financial year 2023, the result moved from € 25,984 to € 65,461. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 29, 2025.
€ 99,060
▲ 195% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 65,461
▲ 152% vs 2023
Profit after tax over the fiscal year.
€ 38,340
▼ 14% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € 29,629.
People and assets in 2024
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 445
▼ 68% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 11,993
▲ € 9,934 vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 9,841
▲ € 9,463 vs 2023
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 68,407 | € 12,167 | € 98,961 | € 81,126 | ▼ 18% |
| Profit after taxes | € 36,851 | € -10,589 | € 25,984 | € 65,461 | ▲ 152% |
| Equity | € 18,204 | € 7,615 | € 33,599 | € 99,060 | ▲ 195% |
| Total debts | € 387,350 | € 368,105 | € 347,901 | € 178,021 | ▼ 49% |
| Cash | € 314 | € 8,138 | € 44,331 | € 38,340 | ▼ 14% |
| Land & buildings | € 137,198 | € 130,905 | € 124,612 | € 118,428 | ▼ 5% |
| Retained profit | € -51,227 | € -61,816 | € -35,832 | € 29,629 | ▲ € 65,461 |
| Balance sheet total | € 405,554 | € 375,720 | € 381,500 | € 277,081 | ▼ 27% |
Key figures of PHARMA SOLUTIONS, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to PHARMA SOLUTIONS?
What happened at PHARMA SOLUTIONS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 65,461 (▲ 152% vs 2023). filed late Source: NBB ↗
- Bart Waelput became a director. NBB
- New establishment in Beveren-Kruibeke-Zwijndrecht. KBO
- Start of the company according to the CBE. KBO
In short
From € 36,851 profit in 2021 to € 65,461 profit in 2024.
Paid € 24,552 in corporate taxes since 2021.
Best year ever: 2024, with € 65,461 profit.
A new publication or filing at PHARMA SOLUTIONS? We notify you, reason included.
Follow PHARMA SOLUTIONSDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Apotheek Waelput comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMA SOLUTIONSBehind PHARMA SOLUTIONS is Bart Waelput. The shares are held by Apotheek Waelput (10%).
Directors
According to the 2024 annual accounts
since 2023
Shareholders
10%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Vijfstraten 209
9100 Sint-Niklaas
Wolfsbergstraat 6
2070 Beveren-Kruibeke-Zwijndrecht
Active since 7 February 2000
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0468.526.628
- VAT number
- BE 0468.526.628
- Registered office
- Vijfstraten 209, 9100 Sint-Niklaas
- Names & denominations
- PHARMA SOLUTIONS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 21 December 1999
- Peppol
- Active · Active since 12 Jan 2026
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsvoering en beheer
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering